Journal Title:Pharmaceutical Medicine
pharmaceutical Medicine Is A Specialist Discipline Concerned With Medical Aspects Of The Discovery, Development, Evaluation, Registration, Regulation, Monitoring, Marketing, Distribution And Pricing Of Medicines, drug-device And drug-diagnostic Combinations. The Journal Disseminates Information To Support The Community Of Professionals Working In These Highly Inter-related Functions. Key Areas Include Translational Medicine, Clinical Trial Design, Pharmacovigilance, Clinical Toxicology, drug Regulation, Clinical Pharmacology, Biostatistics And Pharmacoeconomics. The Journal Includes:overviews Of Contentious Or Emerging Issues.comprehensive Narrative Reviews That Provide An Authoritative Source Of Information On Topical Issues.systematic Reviews That Collate Empirical Evidence To Answer A Specific Research Question, Using Explicit, Systematic Methods As Outlined By Prisma Statement.original Research Articles Reporting The Results Of Well-designed Studies With A Strong Link To Wider Areas Of Clinical Research.additional Digital Features (including Animated Abstracts, Video Abstracts, Slide Decks, Audio Slides, Instructional Videos, Infographics, Podcasts And Animations) Can Be Published With Articles; These Are Designed To Increase The Visibility, Readership And Educational Value Of The Journal’s Content. In Addition, Articles Published In Pharmaceutical Medicine May Be Accompanied By Plain Language Summaries To Assist Readers Who Have Some Knowledge Of, But Not In-depth Expertise In, The Area To Understand Important Medical Advances.all Manuscripts Are Subject To Peer Review By International Experts. Letters To The Editor Are Welcomed And Will Be Considered For Publication.
制藥醫(yī)學是一門專業(yè)學科,涉及藥品、藥品設備和藥物診斷組合的發(fā)現(xiàn)、開發(fā)、評估、注冊、監(jiān)管、監(jiān)測、營銷、分銷和定價的醫(yī)學方面。該期刊傳播信息以支持在這些高度相關的功能中工作的專業(yè)人員社區(qū)。關鍵領域包括轉化醫(yī)學、臨床試驗設計、藥物警戒、臨床毒理學、藥物監(jiān)管、臨床藥理學、生物統(tǒng)計學和藥物經(jīng)濟學。該期刊的內(nèi)容包括:對有爭議或新興問題的概述;全面的敘述性綜述,為專題問題提供權威信息來源;系統(tǒng)評價,使用 Prisma 聲明中概述的明確、系統(tǒng)的方法,匯總經(jīng)驗證據(jù)來回答特定的研究問題;原創(chuàng)研究文章,報告精心設計的研究結果,并與更廣泛的臨床研究領域緊密相關;附加數(shù)字功能(包括動畫摘要、視頻摘要、幻燈片、音頻幻燈片、教學視頻、信息圖表、播客和動畫)可與文章一起發(fā)布;這些功能旨在提高期刊內(nèi)容的可見性、讀者群和教育價值。此外,在《制藥醫(yī)學》上發(fā)表的文章可能會附上通俗易懂的摘要,以幫助對該領域有一定了解但不具備深入專業(yè)知識的讀者了解重要的醫(yī)學進展;所有稿件均經(jīng)過國際專家的同行評審。歡迎致編輯的信函,我們將考慮發(fā)表。
Pharmaceutical Medicine由Springer Nature出版商出版,收稿方向涵蓋PHARMACOLOGY & PHARMACY全領域,平均審稿速度 ,影響因子指數(shù)3.1,該期刊近期沒有被列入國際期刊預警名單,廣大學者值得一試。
| 按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科:PHARMACOLOGY & PHARMACY | ESCI | Q2 | 126 / 354 |
64.5% |
| 按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科:PHARMACOLOGY & PHARMACY | ESCI | Q2 | 136 / 354 |
61.72% |
名詞解釋:
WOS即Web of Science,是全球獲取學術信息的重要數(shù)據(jù)庫,Web of Science包括自然科學、社會科學、藝術與人文領域的信息,來自全世界近9,000種最負盛名的高影響力研究期刊及12,000多種學術會議多學科內(nèi)容。給期刊分區(qū)時會按照某一個學科領域劃分,根據(jù)這一學科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區(qū)中,最后的劃分結果分別是Q1,Q2,Q3,Q4,Q1代表質量最高。
| CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||
| 5.1 | 0.732 | 0.926 |
|
名詞解釋:
CiteScore:衡量期刊所發(fā)表文獻的平均受引用次數(shù)。
SJR:SCImago 期刊等級衡量經(jīng)過加權后的期刊受引用次數(shù)。引用次數(shù)的加權值由施引期刊的學科領域和聲望 (SJR) 決定。
SNIP:每篇文章中來源出版物的標準化影響將實際受引用情況對照期刊所屬學科領域中預期的受引用情況進行衡量。
| 是否OA開放訪問: | h-index: | 年文章數(shù): |
| 未開放 | - | 44 |
| Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
| 41.41% | 3.1 | |
| 研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預警名單(試行)》名單: |
| 68.18% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶需要出版服務,請聯(lián)系出版商。